Message from the Director
The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
CDD Research Among Top 10 Technologies of 2012
CDD Research on functional cosmetics for the protection and repair of photodamaged skin has been featured among top 10 technologies from the U
CDD Research Highlighted in MNDaily
Christine Salomon: Underground Research Drives Drug Research
Center for Drug Design's Research on Popcorn Additive, Diacetyl (DA), and its relationship with Alzheimer's Disease featured in Chemical & Engineering News (C&EN)
A recently reported study out of the laboratories of Prof Robert Vince (Director, Center for Drug Design), raises concern about chronic exposure of workers in industry to a food flavoring ingredient used to produce the distinctive buttery flavor and aroma of microwave popcorn, margarines, snack foods, candy, baked goods, pet foods and other products. Evidence that the ingredient, diacetyl (DA), intensifies the damaging effects of an abnormal brain protein linked to Alzheimer’s disease has been found. The study appears in American Chemical Society's (ACS) journal, Chemical Research in Toxicology and has been featured in July 23 edition of the Chemical and Engineering News magazine of ACS.
Title: Harnessing an Innate DNA Damage Pathway to Prevent and Treat Cancer
Date: April 23, 2014; Time: 10:30 AM; Venue: Mayo Auditorium
Dr. Barbara A. Gilchrest, MD (Professor of Dermatology, Boston University School of Medicine, Boston MA) has clinical and laboratory-based research interests in skin aging and pigmentation and has published extensively based on her pioneering work in these fields. At present, she is conducting clinical studies of novel means to prevent and treat UV-related skin cancers.